• 10 mM dNTP Mixture: Optimizing DNA Synthesis and Delivery

  2026-07-29

  Unlock reproducible, high-fidelity DNA synthesis and advanced nucleic acid delivery with the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture from APExBIO. Discover actionable workflow enhancements and troubleshooting strategies grounded in recent mechanistic insights into nanoparticle-mediated delivery.

• IMPDH Inhibition Restricts PEDV Replication via Nucleotide D

  2026-07-29

  This study uncovers how porcine epidemic diarrhea virus (PEDV) manipulates host IMPDH-dependent guanine nucleotide biosynthesis to promote viral replication. By demonstrating that both genetic and pharmacological inhibition of IMPDH—specifically with Merimepodib (VX-497)—significantly impairs PEDV propagation, the research highlights IMPDH as a promising host-directed antiviral target.

• ARCA Capped mRNA Synthesis: Driving Translational Cancer Vac

  2026-07-28

  This article explores the mechanistic and strategic imperatives for high-fidelity ARCA capped and polyadenylated mRNA synthesis in the development of advanced cancer vaccines, illuminating how new synthesis technologies like the HyperScribe™ All in One mRNA Synthesis Kit empower translational researchers to actualize next-generation immunotherapies. By connecting the dots from bench to bedside—anchored in recent evidence from spleen-targeted neoantigen mRNA vaccines for hepatocellular carcinoma—readers gain actionable insight into optimizing mRNA workflows for robust, clinically relevant output.

• 10 mM dNTP Mixture: Precision DNA Synthesis & Advanced PCR

  2026-07-28

  Unlock superior PCR, DNA sequencing, and LNP assay reproducibility with the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture. Discover actionable protocols, troubleshooting solutions, and workflow optimizations that set this DNA synthesis reagent apart for high-fidelity molecular biology research.

• Streptavidin-FITC: Illuminating Biotin Detection & LNP Traff

  2026-07-27

  Explore the advanced science of Streptavidin-FITC in biotin detection and lipid nanoparticle (LNP) trafficking. This article integrates mechanistic insights, protocol guidance, and unique interpretation of recent breakthroughs to elevate your fluorescent assay workflows.

• Aurora Kinase A Overexpression in Retinoblastoma: Targeting

  2026-07-27

  A recent study demonstrates that Aurora kinase A (AURKA) is consistently overexpressed in human retinoblastoma and correlates with adverse histopathological features and poor chemotherapy response. These findings provide a compelling rationale for investigating selective AURKA inhibition as a targeted therapeutic strategy in high-risk or refractory retinoblastoma.

• Silk Fibroin–Ce6 Electrospun Films Enable Antibacterial PDT

  2026-07-26

  This study presents an aligned silk fibroin nanofiber film conjugated with Chlorin e6 (Ce6), advancing photodynamic antibacterial therapy (PDAT) for Staphylococcus aureus-infected wounds. The engineered scaffold demonstrates rapid bacterial eradication and promotes immune modulation, offering a biocompatible strategy to combat antibiotic-resistant infections.

• PTX3 Mitigates Steroid-Induced ONFH via TLR4/NF-κB-FGF21 Axi

  2026-07-25

  This study uncovers pentraxin 3 (PTX3) as a protective factor against glucocorticoid-induced osteonecrosis of the femoral head (ONFH), operating through the TLR4/NF-κB-FGF21 signaling pathway. The findings highlight a novel mechanistic axis with implications for bone-loss prevention and ER stress research models.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-07-24

  Anlotinib hydrochloride stands out as a potent, selective multi-target tyrosine kinase inhibitor enabling high-sensitivity angiogenesis and tumor proliferation research. Learn how this APExBIO compound empowers advanced endothelial cell migration inhibition and ERK pathway studies—with protocol-ready parameters and troubleshooting insight for reproducible results.

• Azilsartan Medoxomil Monopotassium: Mechanistic Advances in

  2026-07-24

  Explore how Azilsartan medoxomil monopotassium, a potent AT1 receptor antagonist, drives innovation in essential hypertension treatment research. This article offers a mechanistic deep dive and advanced protocol insights not covered in existing reviews.

• Strategic PI3K Activation: 740 Y-P for Translational Innovat

  2026-07-23

  This thought-leadership article dissects the mechanistic underpinnings and translational potential of 740 Y-P, a potent PI3K activator, for researchers advancing apoptosis, vesicular trafficking, and neuronal survival studies. Integrating recent findings on PI3K/AKT/mTOR modulation, the piece offers strategic protocol advice and positions 740 Y-P by APExBIO as a critical tool for bridging cellular insights with workflow optimization in disease models.

• RG108 (SKU A1913): Rigorous Epigenetic Modulation for Cell A

  2026-07-23

  This article delivers a scenario-driven, evidence-based guide to using RG108 (SKU A1913) for precise epigenetic gene regulation modulation in cell-based viability, proliferation, and cytotoxicity assays. Drawing from validated protocols, peer-reviewed literature, and real-world laboratory challenges, it demonstrates how RG108 addresses reproducibility, sensitivity, and workflow safety for advanced cancer research and stem cell differentiation studies.

• TSPAN18-STIM1 Axis Drives Bone Metastasis via Calcium Signal

  2026-07-22

  Zhou et al. identify TSPAN18 as a novel regulator of STIM1 stability, promoting store-operated calcium entry (SOCE) and facilitating bone metastasis in prostate cancer. Their mechanistic and translational findings clarify the molecular link between TSPAN18, TRIM32-mediated ubiquitination, and heightened calcium signaling, suggesting new therapeutic targets in advanced PCa.

• In Vitro Efficacy of Sisomicin vs. Tobramycin on Clinical Is

  2026-07-22

  The reference study by Stewart and Bodey systematically compared the in vitro antibacterial activity of sisomicin, a novel aminoglycoside, with established agents such as tobramycin and gentamicin on a broad panel of clinical isolates. Their findings clarified the relative potency and spectrum of these antibiotics, providing critical insights for antibiotic selection and resistance surveillance in clinical and research microbiology.

• Silybin A (SKU N1711): Reliable Solutions for Cell-Based Ass

  2026-07-21

  Silybin A (SKU N1711) offers reproducibility and validated purity for cell viability, proliferation, and cytotoxicity assays, addressing key workflow challenges faced by labs. This scenario-driven article demonstrates how Silybin A’s physicochemical properties and quality control data from APExBIO support evidence-based research in hepatoprotective and metabolic studies.

14931 records 1/996 page Next 12345 下5页 Last page